Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease.
Tao XieRong HuangDaishuo DengPeipei TangYufeng FuYulong ZhengYufeng WanPublished in: International journal of chronic obstructive pulmonary disease (2023)
Cryptotanshinone restores corticosteroid sensitivity induced by oxidative stress via inhibition of PI3Kδ and is a potential treatment for corticosteroid-insensitive diseases such as COPD.